MDLinxThis Popular Diet May Increase Cancer Risk

Read the original article

A recent study from MIT challenges the widely held belief that intermittent fasting (IF) universally promotes longevity and reduces cancer risk. The research, conducted on mice, suggests that the refeeding period following a fast may actually increase the potential for tumor growth in certain genetic conditions. This finding calls for a closer examination of fasting protocols and their effects on cellular regeneration, particularly in the context of cancer risk.

Key Points:

• Intermittent fasting has gained popularity for its purported health benefits beyond weight loss.
• A 2024 MIT study on mice found that cell proliferation in intestinal stem cells was highest during the refeeding phase after a 24-hour fast.
• The post-fast refeeding period was identified as a distinct state with greater potential for tumor proliferation compared to fasted or continuously fed states.
• These findings contradict previous research supporting the anticancer benefits of fasting.
• The study suggests that careful consideration should be given to fast-refeeding cycles when planning diet-based strategies for regeneration.
• The refeeding process after a fast may require special attention to avoid exposure to carcinogens during this potentially vulnerable time.
• Although the study was conducted on mice, it raises important questions about optimal fasting and refeeding conditions for humans.

“Given our findings, fast-refeeding cycles must be carefully considered and tested when planning diet-based strategies for regeneration without increasing cancer risk, as post-fast refeeding leads to a burst in stem-cell-driven regeneration and tumorigenicity.”

More on Diet & Nutrition